Jonathan Embleton is listed as a director on 2 SEC Form D filings by 1 issuer in Apr 2009: Handa Pharmaceuticals, LLC (Fremont, CA — pharmaceuticals — 2009; $2.04M reported sold to 7 investors).
What this means One deal on file with the SEC, filed Apr 2009. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Fang-Yu Liu (2 shared filings), Meifang Chang (2 shared filings) and Stephen Cary (2 shared filings).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Jonathan. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), state securities regulators (AZ, CA, DE, TX, WA) — 1 court case matching the name, 6 bankruptcy cases matching the name listed in Key records below. Not yet searched: SEC enforcement releases (search queued; results are added automatically).
What this means 7 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.